Aurlumyn Injection, Solution
Product Images NDC 50633-340

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Aurlumyn (NDC 50633-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Btg International Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton Label (Aurlumyn Carton Label Jpg 1mb)

Carton Label (Aurlumyn Carton Label Jpg 1mb)
This is a description of AURLUMYN™ (iloprost) Injection, which is a medication used for intravenous infusion only. The product needs to be diluted before use and comes in 1 mL single-dose vials. Each mL contains 100 mcg iloprost, 8.1 mg ethanol, 9 mg sodium chloride, 0.242 mg tromethamine, and water for injection. The recommended storage temperature is 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It is important not to freeze the product or expose unopened vials to direct sunlight. The manufacturer is BTG International Inc. in West Conshohocken, PA, 19428, and the product is made in the United States.*
FDA Label Image

Aurlumyn Vial Label (Aurlumyn Vial)

Aurlumyn Vial Label (Aurlumyn Vial)
FDA Label Image

Chemical Structure (Aurlumyn 01)

Chemical Structure (Aurlumyn 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.